| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $1.1M | — | +23.1% |
| SG&A Expense | $1.2M | — | -33.4% |
| Operating Income | -$2.2M | — | +14.5% |
| Pre-tax Income | -$2.2M | — | +15.8% |
| Income Tax | $192K | — | +860.0% |
| Net Income | -$2.2M | — | -148.2% |
| EPS (Basic) | -$0.05 | — | -145.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.0M | -48.2% | -38.2% |
| Short-term Investments | $3.8M | -19.9% | +91.3% |
| Current Assets | $13.5M | -35.3% | -57.2% |
| Total Assets | $18.4M | -29.0% | -50.4% |
| Current Liabilities | $12.4M | -8.9% | -2.3% |
| Total Liabilities | $48.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.3M | — | +21.9% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $4.5M | — | -28.9% |
| Financing Cash Flow | -$4.2M | — | — |
| Free Cash Flow | -$3.3M | — | +22.9% |
| -2.0% |
| Stockholders' Equity | -$34.5M | -7.2% | -21.8% |